A Senate panel has recommended approval of Dr. Stephen Hahn as the new commissioner of the FDA.
The U.S. Senate Committee on Health, Education, Labor & Pensions voted 18 to 5 to approve the nomination of Hahn, the chief medical officer at Houston’s M.D. Anderson Cancer Center. Hahn would replace acting commissioner Dr. Brett Giroir, the current assistant secretary for health.
If approved by the full Senate, Hahn would be the fourth person to lead the FDA within the past year. Giroir replaced Dr. Ned Sharpless as acting commissioner when President Donald Trump nominated Hahn for commissioner last month. Dr. Scott Gottlieb, also a Trump nominee, resigned from the commissioner’s role in April.